Showing 1 - 3 results of 3 for search 'A. E. van Leeuwen', query time: 0.04s Refine Results
  1. 1
    Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design

    Personalized surveillance and aftercare for non-metastasized breast cancer: the NABOR study protocol of a multiple interrupted time series design by A. Klaassen-Dekker, C. H. C. Drossaert, M. C. Van Maaren, A. E. Van Leeuwen-Stok, V. P. Retel, J. C. Korevaar, S. Siesling, on behalf of the NABOR project group

    Published 2023-11-01
    Get full text
    Article
  2. 2
    Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade

    Tumor-infiltrating lymphocytes in HER2-positive breast cancer treated with neoadjuvant chemotherapy and dual HER2-blockade by M. C. Liefaard, A. van der Voort, M. van Seijen, B. Thijssen, J. Sanders, S. Vonk, L. Mittempergher, R. Bhaskaran, L. de Munck, A. E. van Leeuwen-Stok, R. Salgado, H. M. Horlings, E. H. Lips, G. S. Sonke

    Published 2024-04-01
    Get full text
    Article
  3. 3
    BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer

    BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer by M. C. Liefaard, A. van der Voort, M. S. van Ramshorst, J. Sanders, S. Vonk, H. M. Horlings, S. Siesling, L. de Munck, A. E. van Leeuwen, M. Kleijn, L. Mittempergher, M. M. Kuilman, A. M. Glas, J. Wesseling, E. H. Lips, G. S. Sonke

    Published 2023-06-01
    Get full text
    Article

Search Tools: